Gastroesophageal reflux disease stimulation of NSAID-associated atrial fibrillation

Archives of Internal Medicine

Volumn 171, Issue 7, 2011, Pages 704-705

  Daniell, Harry W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

DISEASE ASSOCIATION; DRUG SAFETY; EDITORIAL; ESOPHAGITIS; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; INTERVIEW; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATRIAL FIBRILLATION; GASTROESOPHAGEAL REFLUX; HUMANS; PROTON PUMP INHIBITORS;

EID: 79955065847     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.107     Document Type: Editorial

References (5)

1. De Caterina R, Ruigómez A, Rodríguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med. 2010;170(16):1450-1455.
2. Bunch TJ, Packer DL, Jahangir A, et al. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. AmJ Cardiol. 2008;102(9):1207-1211.
3. Weigl M, Gschwantler M, Gatterer E, Finsterer J, Stöllberger C. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. South Med J. 2003;96(11):1128-1132.
4. Gerson LB, Friday K, Triadafilopoulos G. Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. J Clin Gastroenterol. 2006; 40(9):828-832.
5. Swanson DR. Running, esophageal acid reflux, and atrial fibrillation: a chain of events linked by evidence from separate medical literatures. Med Hypotheses. 2008;71(2):178-185.